Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pritelivir for Acyclovir-resistant Mucocutaneous HSV Infections in Immunocompromised Subjects
NCT03073967Phase 3Completed
- Sponsor
- AiCuris
- Start
- May 2017
- Primary completion
- Aug 2025
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 15
01
Overview
A Phase 3 trial of pritelivir in herpes simplex virus infection, sponsored by AiCuris. Started May 2017; status: completed.
02
Drugs
pritelivir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT03073967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03073967.